Checkpoint Capital L.P. Revolution Medicines, Inc. Transaction History
Checkpoint Capital L.P.
- $215 Billion
- Q2 2025
A detailed history of Checkpoint Capital L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Checkpoint Capital L.P. holds 280,000 shares of RVMD stock, worth $13.1 Million. This represents 4.8% of its overall portfolio holdings.
Number of Shares
280,000
Previous 392,011
28.57%
Holding current value
$13.1 Million
Previous $13.9 Billion
25.68%
% of portfolio
4.8%
Previous 7.61%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
333Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$736 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$669 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$626 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$495 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$479 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.1B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...